Keywords: Deuterium, Deuterium, Glioblastoma, epilepsy, metabolic modeling
Motivation: To get insight into altered brain glucose metabolism in epilepsy and glioblastoma.
Goal(s): To assess glucose metabolism in glioblastoma, epileptogenic, and healthy brain tissue by analyzing the tricarboxylic acid cycle rate (VTCA) using deuterium metabolic imaging (DMI) and metabolic modeling.
Approach: Dynamic DMI data were acquired in five healthy controls, five epilepsy patients and five glioblastoma patients. A metabolic model was used to estimate VTCA across different ROIs.
Results: VTCA is lower in glioblastoma tissue than in healthy controls. No difference was found between epileptogenic and healthy tissue or epileptogenic and glioblastoma tissue, although the results depend heavily on assumed Glx pool sizes.
Impact: This study demonstrates the potential of deuterium metabolic imaging with metabolic modeling to estimate the tricarboxylic acid cycle rate in brain tissue, providing insights into epilepsy and glioblastoma. Findings could enhance non-invasive diagnostics and individualized treatment strategies.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords